home / stock / aytu / aytu short
Short Information | Aytu BioPharma Inc. (NASDAQ:AYTU)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 97,272 |
Total Actual Volume | 360,415 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 1 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 4,864 |
Average Short Percentage | 27.06% |
Is there a AYTU Short Squeeze or Breakout about to happen?
See the AYTU Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-18-2024 | $2.87 | $2.79 | $2.932 | $2.79 | 3,294 | 162 | 4.92% |
04-17-2024 | $2.94 | $2.8733 | $2.94 | $2.7596 | 4,312 | 518 | 12.01% |
04-16-2024 | $2.68 | $2.86 | $2.92 | $2.68 | 7,382 | 1,768 | 23.95% |
04-15-2024 | $2.85 | $2.68 | $2.86 | $2.65 | 55,660 | 14,451 | 25.96% |
04-12-2024 | $3.11 | $2.8899 | $3.1202 | $2.8369 | 26,498 | 2,381 | 8.99% |
04-11-2024 | $3.22 | $3.12 | $3.22 | $3.0825 | 26,603 | 6,610 | 24.85% |
04-10-2024 | $3.27 | $3.2166 | $3.38 | $3.15 | 13,404 | 3,099 | 23.12% |
04-09-2024 | $3.27 | $3.36 | $3.38 | $3.27 | 13,225 | 3,048 | 23.05% |
04-08-2024 | $3.1 | $3.3 | $3.35 | $3.1 | 40,063 | 12,703 | 31.71% |
04-05-2024 | $3.16 | $3.22 | $3.22 | $3.0919 | 15,837 | 3,454 | 21.81% |
04-04-2024 | $3.1 | $3.2 | $3.2 | $2.9823 | 21,840 | 3,616 | 16.56% |
04-03-2024 | $3.04 | $3.13 | $3.13 | $3.04 | 12,051 | 5,954 | 49.41% |
04-02-2024 | $2.98 | $3.03 | $3.04 | $2.98 | 10,254 | 5,823 | 56.79% |
04-01-2024 | $3.07 | $2.99 | $3.17 | $2.9696 | 15,658 | 3,015 | 19.26% |
03-28-2024 | $3.1 | $3.04 | $3.12 | $3.0109 | 15,205 | 3,225 | 21.21% |
03-27-2024 | $3.0751 | $3.08 | $3.085 | $2.91 | 13,824 | 6,127 | 44.32% |
03-26-2024 | $3.03 | $3.08 | $3.09 | $3.03 | 7,483 | 2,688 | 35.92% |
03-25-2024 | $3.04 | $3.055 | $3.17 | $2.975 | 41,452 | 13,764 | 33.2% |
03-22-2024 | $3.01 | $3.04 | $3.11 | $2.9401 | 6,171 | 2,580 | 41.81% |
03-21-2024 | $2.89 | $2.98 | $3.0702 | $2.8719 | 10,199 | 2,286 | 22.41% |
News, Short Squeeze, Breakout and More Instantly...
Q2 2024 operating income of $2.4 million Q2 2024 net loss of $0.2 million and adjusted EBITDA 1 of $5.1 million Q2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted EBITDA of $5.5 million Q2 2024 ADHD Portfolio net revenue up 49% compared to Q2...
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial and operational results for its second quarter of fiscal 2024 for the period ended December...